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Introduction: The average lifespan in the United States continues to lengthen. We have observed a similar trend in our
patients, with an increased number of nonagenarians presenting for evaluation of vascular disease. This study evaluated
outcomes of lower extremity revascularization in patients aged >90 years.
Methods: The vascular registry at Albany Medical College was retrospectively reviewed for all lower extremity bypasses
performed between 1996 and 2006. We evaluated patient demographics, indications, procedure, patency rates, and
complications. Patients were divided into groups based on age >90 years (>90 group) and <90 years (<90 group).
Variables were evaluated by 2 analysis. Outcomes were prepared using life-table methods and compared with log-rank
analysis.
Results: During the last 10 years, 5443 lower extremity bypasses were performed on patients aged <90 years and 150 on
patients aged>90 years. The<90 group had significantly more men (61.4% vs 29.3%) and was obviously younger, at 68
years (range 7-89 years) vs 92 years (range, 90-101 years). The <90 group had more comorbidities in terms of diabetes,
active tobacco use, and hypercholesterolemia. No significant difference was noted in coronary artery disease or chronic
renal insufficiency between the groups. Critical limb ischemia as an indication was significantly higher in the >90 group
(149 [99%] vs 4472 [82%]; P< .0.5). Strikingly, the primary patency was significantly higher in the>90 group at 4 years
(77% vs 62%; P < .05). Complication and amputation rates did not differ between the groups. Perioperative (15% vs 3%;
P < .05) and 1-year (45% vs 11%; P < .05) mortality rates were significantly higher in the >90 group.
Conclusion: Lower extremity bypass for nonagenarians offers acceptable patency and limb salvage but at a significantly
higher mortality rate. ( J Vasc Surg 2009;49:1459-64.)The American population has continued to age during
the last two census periods, and the population aged 85
years is projected to increase by 43% from 2000 to 2010.1
The number of nonagenarians referred for limb ischemia to
our offices has increased accordingly with the aging popu-
lation. Limb revascularization and limb salvage in the el-
derly has been studied and deemed safe; however, no series
has addressed the nonagenarian population exclusively.2-4
We analyzed our experience with vascular reconstruction in
patients aged 90 years of age by reviewing our results for
limb salvage and patient survival.
METHODS
The vascular registry at Albany Medical College was
retrospectively reviewed for all lower extremity bypasses
performed between 1996 and 2006. We evaluated patient
demographics, indications, procedure, patency rates, com-
plications, and mortality rates. Comorbidities for each pa-
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doi:10.1016/j.jvs.2009.02.012tient were defined as a medical diagnosis actively being
treated by a primary physician. The indications for proce-
dure were recorded based on standard nomenclature.5
The management strategy involved all patients with
potentially salvageable limbs undergoing standard contrast
angiography before any revascularization. If the treating
physician determined the lesion was not amenable to an-
gioplasty or stenting, then the options of open bypass,
primary amputation, and observation were discussed with
the patient. A final decision was agreed upon according to
patient and individual surgeon preference. The treatment
decision was founded on overall medical condition and
general patient appearance.
The methods and specifics of revascularization was
decided by group conference, and the best possible option
was used to salvage the limb regardless of age. Most proce-
dures were performed under general anesthesia using low-
dose heparin anticoagulation, without the need for prota-
mine after the procedure.
Postprocedural follow-up involved pulse volume re-
cordings2 weeks, at 3 months, and then every 6 months.
Interrogation of all autogenous bypass grafts with duplex
ultrasound imaging occurred every 6 months according to
practice protocol. Limb salvage was defined as avoidance of
below or above knee amputation. Patency rates were re-
corded in terms of primary vs secondary patency. The
patients were divided into groups based on age 90 years
and 90 years. The variables were compared using 2
analysis. The outcomes were prepared using life-table
methods and compared with log-rank analysis.
1459
JOURNAL OF VASCULAR SURGERY
June 20091460 Hnath et alRESULTS
Between 1996 and 2006, 5593 lower extremity by-
passes were performed at our institution, 5443 in the 90
group and 150 in the 90 group. The 90 group had
significantly more men than the90 group (3341 [61.4%]
vs 44 [29.3%]; P  .05). The 90 group had more risk
factors for atherosclerosis such as diabetes (2697 [50%] vs
38 [25%]; P  .05), tobacco use (1747 [32.1%] vs 10
[6.7%]; P .05), and hypercholesterolemia (2754 [50.6%]
vs 45 [30%]; P  .05). The groups were similar in the
presence of coronary artery disease, hypertension, and renal
insufficiency. The90 group hadmore chronic obstructive
pulmonary disease than the 90 group (63 [42%] vs 646
[11.9%]; P  .05; Table I).
The indications for peripheral revascularization were
different between the two groups secondary to the 90
group having significantly more critical limb ischemia (Ta-
ble II). Ten procedures in the 90 group were performed
for symptoms resulting from a failed older bypass. These 10
revascularizations all used the common femoral artery for
inflow and the outflowwas a tibial vessel. The inflow for the
bypasses was similar between groups except for increased
use of the superficial femoral artery in the 90 group, (39
[26%] vs 980 [18%]; P  .05; Table III). The outflow
vessels were different with regards to more above knee
(1133 [20.8%] vs 19 [12.7%]; P  .05) and below knee
(1228 [22.6%] vs 22 [14.7%]; P  .05) popliteal artery
Table I. Demographics
Variablea 90 y 90 y P
No. of patients 5443 150
Male 3341 (61.4) 44 (29.3) .05
Age, y 68 (7-89) 92 (90-101) .05
Diabetes 2697 (50) 38 (25) .05
Tobacco use 1747 (32.1) 10 (6.7) .05
Coronary disease 3439 (63.2) 91 (60.8) NS
Hypertension 4087 (75.1) 108 (72) NS
Hypercholesterolemia 2754 (50.6) 45 (30) .05
COPD 646 (11.9) 63 (42) .05
Renal insufficiency 1066 (19.6) 21 (14) NS
COPD, Chronic obstructive pulmonary disease; NS, not significant.
aCategoric data are expressed as number (%); continuous data as mean-
(range).
Table II. Indications
Indication
90 y 90 y
PNo. (%) No. (%)
Claudication 971 (17.8) 1 (0.7) .05
Rest pain 1194 (21.9) 31 (20.7) NS
Ulcer 1995 (36.7) 76 (50.7) .05
Gangrene 1057 (19.4) 39 (26) .05
Aneurysm 144 (2.7) 3 (2) NS
Trauma 44 (0.8) 0 NS
Atheroemboli 38 (0.7) 0 NS
NS, Not significant.bypasses in the 90 group and more use of the peronealartery in the 90 group (55 [36.7%] vs 919 [16.9%]; P 
.05; Table IV). The conduit used for bypass was similar in
both groups (Table V). The groups sustained similar post-
operative complications, except for a higher wound infec-
tion rate (399 [7.3%] vs 1 [0.7%]; P  .05) in the 90
group (Tables VI and VII).
The overall primary patency rates were better at 4 years
in the 90 group, at 77.3% vs 62.1% (P  .05), but this
significance was lost after 4 years of follow-up due to the
small number of survivors (Fig 1). Secondary patency rates
at 5 years were not significantly different, at 82.9% vs 70.8%
(P  NS; Fig 2). Further comparison based on popliteal vs
tibial outflow showed no significant difference in patency
between the 90 and 90 groups (Fig 3). All revisions of
Table III. Inflow vessels
Inflow
90 y 90 y
PNo. (%) No. (%)
Graft/iliac artery 458 (8.4) 12 (8) NS
Common femoral artery 2686 (49.4) 80 (53.3) NS
Superficial femoral artery 980 (18) 39 (26) .05
Profunda femoris artery 472 (8.7) 8 (5.3) NS
Axillary artery 5 (0.1) 0 NS
Above knee popliteal artery 154 (2.8) 2 (1.3) NS
Below knee popliteal artery 598 (11) 9 (6) NS
Tibioperoneal trunk 3 (0.1) 0 NS
Anterior tibialis artery 39 (0.7) 0 NS
Posterior tibialis artery 22 (0.4) 0 NS
Peroneal artery 21 (0.4) 0 NS
Dorsalis pedis artery 5 (0.1) 0 NS
NS, Not significant.
Table IV. Outflow vessels
Outflow
90 y 90 y
PNo. (%) No. (%)
Above knee popliteal artery 1133 (20.8) 19 (12.7) .05
Below knee popliteal artery 1228 (22.6) 22 (14.7) .05
Tibioperoneal trunk 39 (0.7) 0 NS
Anterior tibialis artery 825 (15.2) 19 (12.7) NS
Posterior tibialis artery 742 (13.6) 19 (12.7) NS
Peroneal artery 919 (16.9) 55 (36.7) .05
Dorsalis pedis artery 523 (9.6) 16 (10.7) NS
Plantar artery 27 (0.5) 0 NS
Tarsal artery 7 (0.1) 0 NS
NS, Not significant.
Table V. Conduit
Conduit
90 y 90 y
PNo. (%) No. (%)
Prosthetic 1355 (24.9) 33 (22) NS
In situ bypass 2239 (41.1) 73 (48.7) NS
Excised vein 1283 (23.6) 30 (20) NS
Spliced vein 566 (10.4) 14 (9.3) NS
NS, Not significant.the90 group bypass stenoses were performed using open
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ously in the 90 group. The limb salvage rates between in
the groups were also similar (Fig 4).
The 90 group mortality rate was significantly higher
than the90 group at 30 days (15.1% vs 3.3%; P .05), 1
year (44.9% vs 11.3%; P  .05), and 5 years (92.2% vs
34.0%; P  .05; Fig 5). The causes of death in the 30-day
postoperative period in the 90 group were cardiac in 19
(86.4%), stroke in two (9.0%), and multisystem organ
Table VI. Local complications
Complications
90 y 90 y
PNo. (%) No. (%)
Wound infection 399 (7.3) 1 (0.7) .05
Lymphocele 41 (0.8) 1 (0.7) NS
Bleeding 188 (3.5) 2 (1.3) NS
Immediate occlusion 307 (5.6) 7 (4.7) NS
Arteriovenous fistula 76 (1.4) 4 (2.7) NS
Retained valve 56 (1) 0 NS
Proximal vein bypass stenosis 123 (2.3) 1 (0.7) NS
Middle vein bypass stenosis 150 (2.8) 2 (1.3) NS
Distal vein bypass stenosis 135 (2.5) 2 (1.3) NS
Native artery inflow stenosis 61 (1.1) 1 (0.7) NS
Native artery outflow stenosis 54 (1) 1 (0.7) NS
Graft infection 76 (1.4) 1 (0.7) NS
NS, Not significant.
Table VII. Systemic nonfatal complications
Nonfatal complications
90 y 90 y
PNo. (%) No. (%)
Cardiac 57 (1.1) 2 (1.3) NS
Renal 8 (0.2) 1 (0.7) NS
Pulmonary 18 (0.3) 0 NS
Stroke 7 (0.1) 0 NS
Sepsis 6 (0.1) 0 NS
Colon ischemia 1 (0.02) 0 NS
MOS 17 (0.3) 0 NS
MOS, Multisystem organ failure; NS, not significant.
Fig 1. Primary patency. Data are presented with the standard
deviation.failure in one (4.5%). The mean length of follow-up was 28months (range, 1-140 months) for the 90 group and 22
months (range, 1-74 months) for the 90 group.
DISCUSSION
The United States population is continually aging, and
with this trend, more nonagenarian patients have been
Fig 2. Secondary patency. Data are presented with the standard
deviation.
Fig 3. Popliteal and tibial patency patentcy rates. Data are pre-
sented with the standard deviation.
Fig 4. Limb salvage rates. Data are presented with the standard
deviation.referred to our facility for treatment of limb ischemia. The
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approximately 5 years, and this findingmay preclude simple
observation of a limb with severe pain or gangrene.6 The
goal of our practice is to salvage limbs, relieve ischemic
pain, and preserve ambulatory status whenever feasible. If
the patient is deemed an acceptable risk from a medical and
surgical standpoint, revascularization is offered. The aging
of the population is a newly evolving process, and little data
are available to support or negate open revascularization in
nonagenarians. Multiple series have focused on peripheral
revascularization for octogenarians and nonagenarians, but
this is a large series primarily focused on limb revasculariza-
tion in the nonagenarian population. The90 group had a
better primary patency rate and a similar limb salvage rate
compared with the 90 group, but these results are tem-
pered by a significantly higher mortality rate in the 90
group.
The 90 and 90 groups were obviously different in
terms of age, but were also different in sex. The90 group
had a preponderance of women, which may be a reflection
of the overall longer life expectancy of women in the
United States. The rate of diabetes, tobacco use, and hy-
percholesterolemia in the 90 group was significantly less
than the 90 group, and this may have led to less athero-
sclerotic related death. The groups did not differ in rates of
hypertension, coronary artery disease, or renal insuffi-
ciency. This finding is difficult to explain, except that
emergence of these risk factors may have evolved later in life
in the nonagenarians, which in turn may not have had time
to affect survival. The rate of diabetes in the90 group was
approximately half that of the90 group. This findingmay
be explained by the higher early mortality in diabetic indi-
viduals or by the general observed paucity of obese patients
in the 90 group.
The indications for revascularization were different be-
tween the two groups. Almost all procedures performed on
the 90 group were for limb-threatening ischemia. The
preponderance of critical limb ischemia in the90 group is
secondary to a general resistance to operate for any reason
except for limb preservation in this population. It is difficult
Fig 5. Survival rates. Data are presented with the standard
deviation.to elucidate the pattern of disease and symptoms because ofthe lack of data on claudicant patients treated nonopera-
tively in the more elderly population. The atheroemboli
indication for bypass was for treatment of an ulcerated
plaque that resulted in blue toe syndrome. Two symptom-
atic popliteal aneurysms were treated in the 90 group for
compression-related symptoms.
The types of inflow used were largely similar between
groups; however, the superficial femoral artery (SFA) was
used significantly more in the 90 group. An explanation
for this observation may be less plaque formation at the
origin of the SFA in this group. Whether this finding
demonstrates a different age-related distribution of athero-
sclerosis or pattern of calcification in nonagenarians is dif-
ficult to determine without the availability of the angio-
grams. An alternative explanation is that the SFA is
technically easier to expose and less dissection of the vein is
needed for an in situ reconstruction, possibly allowing a
quicker procedure for the patient. The inflow and overall
procedures were generally kept simple to maximize benefit
and minimize complications in the 90 group. This is in
contrast to the more aggressive procedures that were used
in the 90 group, such as a dorsalis pedis to tarsal artery
autogenous bypass.
The difference in atherosclerotic risk factors may have
led to better primary patency in the 90 group. A more
likely explanation is patient selection: The 90 patients
without optimal bypass options may not have been offered
an operation based on surgeon discretion.
The vascular registry is very procedure-oriented and,
unfortunately, does not include ankle brachial indices,
TransAtlantic Inter-Society Consensus classifications, or
even outflow vessel characteristics. These data points might
have demonstrated a divergence in disease patterns be-
tween the age groups that could have helped explain some
of the patency findings. The registry also does not elaborate
on the extent of ulceration or gangrene. These data might
have offered more insight into different disease patterns
between groups.
The difference in secondary patency and limb salvage
was insignificant between the groups. A small gap was
noted between late patency and limb salvage in the 90
group, and this was a reflection of patency and not of
patient mortality.
Most cohorts in most series addressing the elderly
population consist of octogenarians, with only a few nona-
genarians included. Our patency and limb salvage rates are
comparable with those series, but our 90 group had a
much higher mortality rate. The 90 group mortality rate
was 15.1% at 30 days and 44.9% at 1 year. Most of the early
deaths were secondary to perioperative cardiac events. The
prior studies, consisting mostly of octogenarians, had
1-year mortality rates of 8% to 22%.3,4,7-10 Those studies
were able to advocate an aggressive approach to revascular-
ization based on acceptable mortality rates. Perioperative
mortality rates were 2.5% for septuagenarians and 3.2% for
octogenarians. The significantly increased mortality rate in
the 90 group may temper the enthusiasm for aggressive
revascularization. The increased mortality rate of the 90
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narians and nonagenarians when patients are classified as
“elderly.”
Our series has a few limitations. The first pertains to
selection bias. There may have been patients deemed too
infirm to tolerate an operation who were treated nonopera-
tively. Data were not collected on nonoperatively treated
patients or their mortality or limb salvage status.
Another limitation was the lack of data on preoperative
ambulatory and independent living status, which are two
factors that are strong predictors of survival after peripheral
revascularization.2,7 Our database also did not keep records
of postoperative ambulation and quality of life status; we do
not know if any of the surviving 90 patients returned to
independent living.
There has been a nationwide trend toward percutane-
ous intervention for peripheral vascular disease, but our
series did not compare percutaneous intervention with
open procedures in the90 group.Our peripheral stenting
database was initiated in 1999 and up to 2007, and in that
time 1085 peripheral stents were placed. Septuagenarians
accounted for 314 (28.9%) and octogenarians accounted
for 187 (17.2%) peripheral stent procedures. Nonagenari-
ans accounted for nine lower extremity peripheral stents,
with one periprocedural cardiac-related death. Percutane-
ous intervention may offer a less invasive alternative to an
open procedure; however, 1-year mortality rates remain
significantly elevated in the elderly population in these
series.11,12 In accordance with the population changes, our
group has experienced an increase in the number of open
revascularization procedures in the nonagenarian popula-
tion. In light of these new mortality findings, our manage-
ment strategy is evolving toward using more aggressive
percutaneous methods or even nonoperative treatment.
CONCLUSIONS
Our series demonstrates that peripheral revasculariza-
tion can be performed with good patency and limb salvage
rates in nonagenarians, but with a significantly increased
mortality rate. These findings may temper the enthusiasm
for an aggressive approach to limb salvage in the elderly
population and also may have created a distinction between
octogenarians and nonagenarians when classifying patients
as elderly.
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Dr Brian Nolan (Lebanon, NH). I think your question is an
interesting one. The most pertinent finding, in my opinion, was
that nearly half of the patients over age 90 don’t survive 1 year
following major lower extremity revascularization. This begs the
question whether there is value in doing it and how do you select
those patients to whom it is of value? So, the question I have is,
have you analyzed your data using multivariate regression topatient selection? As a follow-up to that, have you looked at any
other age cohorts, like age greater than 80?
Finally, I think in your paper you point out that you reviewed
your entire revascularization experience, including claudicants, of
which therewere significantlymore claudicants in the age90group.
If you controlled for claudication, are your findings still significant?
Dr Jeffrey Hnath. We did not specifically use a multivariate
analysis study, but you bring up an interesting point, and we will
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further analysis. We did not specifically look at the 80-year-old or
even the 70-year-old patient data; we felt that the octogenarian
population had previously been studied.
There were about 20% more claudicants in the 90 popula-
tion in our study, and only one patient 90 received a bypass for
claudication. If we segregate by indication we may find a slight
change in the mortality rate.
Dr Ruth Bush (Temple, Tex). In your Kaplan-Meier curve,
you showed a highmortality rate, which you would expect for folks
over 90, but you didn’t include the number at risk or the confi-
dence interval bars on your patency rate. I think just my comment
would be that that would be important to include in the manu-
script, because I suspect those numbers trickle off quite a bit.
Dr Erica Mitchell (Portland, Ore). Did you look at the
30-day and 1-year mortality rates of 90-year-olds who underwent
amputation, and if so, were they different to that after bypass?
Dr Hnath. We did review our amputation patients, and
actually, the 30-day mortality rate in our above knee amputations
is anywhere from 30% to 45%.
Dr Lee Goldstein (New York, NY). In the last decade you
reported almost 5500 bypasses, which works out to almost 1.5
bypasses every day. I would imagine that volume in the nonage-
narian population in the last few years has significantly decreasedI think the patients that have gotten to be in their 90s would
have a different form of vascular disease if they have gotten that far.
With your patency rates being especially better in that population,
have you thought about comparing, or at least breaking down,
your time frame into an earlier vs a later period and looking at the
impact of endovascular therapies on these older patients?
Dr Hnath. We looked at our endovascular numbers and we
had a surprisingly low number of nonagenarians. We performed a
percutaneous intervention on nine patients in that time span, with
only one mortality. If we get more numbers, then maybe we can
look into it a little further.
Dr Jim Watson (Seattle, Wash). This study provides some
data for what’s been my practice for a long time, which is to
minimize interventions in the older population while avoiding
amputation. As you point out, amputations are devastating in older
patients. However, I have occasionally tolerated small ulcers or
mild gangrene in an elderly patient without intervening, as long as
it doesn’t progress. Some of these problems have healed, and some
patients have died of other causes without treatment of their
ischemia. Obviously, some lesions need intervention. But any
intervention on the elderly carries significant risk of complications,
and whatever we can do to avoid amputation and keep them out of
the hospital is what we should focus on.
Dr Hnath. I agree. We need to be selective about how we
with the advent of aggressive endovascular interventions. treat this population.
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